Clinical Trials Browser

Phase 2/3 × Interventional × Cystadenocarcinoma, Serous × Clear all

NCT02101788 2025-11-13

Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer

Phase 2/3 Completed

260 enrolled 20 charts

Cystadenocarcinoma, Serous

NCT04159155 2025-08-12

CAN-STAMP

Phase 2/3 Terminated

Endometrial Neoplasms, Cystadenocarcinoma, Serous

NCT04055038 2019-08-13

EPITOC

Phase 2/3 Unknown

Ovarian Neoplasms, Cystadenocarcinoma, Serous